If you would like to see your event on this calendar, please email email@example.com.
Events must be related to the field of gynecologic cancers with the target audience of clinicians, researchers, or advocates (patient/survivors/family members/caregivers).
- This event has passed.
Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions
Dec 7, 2022 @ 10:30 am - 11:30 am
Join us for an overview of the InnovaTV 204 trial data along with InnovaTV 205 data, as well as ongoing trials including InnovaTV 301.
Wednesday, December 7, 2022
10:30 AM ET | See all time zones
Duration approximately 30 minutes
Supported in part by Seagen
Robert Coleman, MD
Chief Scientific Officer,
US Oncology Research